Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
about
Discovery of a potent, nonpolyglutamatable inhibitor of glycinamide ribonucleotide transformylaseThe ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibitionFragment-based discovery of novel thymidylate synthase leads by NMR screening and group epitope mapping.Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.The renal effects of the water-soluble, non-folylpolyglutamate synthetase-dependent thymidylate synthase inhibitor ZD9331 in mice.Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1)Imaging pharmacodynamics of the alpha-folate receptor-targeted thymidylate synthase inhibitor BGC 945.The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus.Synthesis, single crystal analysis, biological and docking evaluation of tetrazole derivatives
P2860
Q24653861-29D2AC1F-13D2-43CD-9A3F-465A6643BEA1Q28345394-B18CF854-0688-4CAF-8366-1ACA2751DA81Q33631525-A8E33B36-4F99-4F04-90F7-AEDC3390F175Q35639774-1BDC01DF-3227-4005-A18A-FA160BE1D661Q36115728-32B931CC-4281-4443-A9E0-78F54EA65F2CQ36899323-0412C4B6-5936-4A49-B513-B716F08C0787Q37479804-868AF309-8DB9-436B-87B1-6B5769483F10Q37663377-0268C1BF-3F46-429D-A430-445644A61C54Q40859860-618CB0EE-90DD-47F8-93D6-A862FD2D5C17Q40960308-4FADB1F2-C18D-4EE1-A6DC-229E9CAAFCD0Q58733176-031402E9-EA84-4A37-A9A3-9706FEB8C140
P2860
Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Cellular pharmacology and in v ...... bitor of thymidylate synthase.
@ast
Cellular pharmacology and in v ...... bitor of thymidylate synthase.
@en
type
label
Cellular pharmacology and in v ...... bitor of thymidylate synthase.
@ast
Cellular pharmacology and in v ...... bitor of thymidylate synthase.
@en
prefLabel
Cellular pharmacology and in v ...... bitor of thymidylate synthase.
@ast
Cellular pharmacology and in v ...... bitor of thymidylate synthase.
@en
P2093
P1476
Cellular pharmacology and in v ...... ibitor of thymidylate synthase
@en
P2093
Jackman AL
Stephens TC
Wardleworth JM
P304
P407
P577
1997-06-01T00:00:00Z